Cite
Ligustrazine Nanoparticle Hitchhiking on Neutrophils for Enhanced Therapy of Cerebral Ischemia‐Reperfusion Injury.
MLA
Mu, Qingchun, et al. “Ligustrazine Nanoparticle Hitchhiking on Neutrophils for Enhanced Therapy of Cerebral Ischemia‐Reperfusion Injury.” Advanced Science, vol. 10, no. 19, July 2023, pp. 1–10. EBSCOhost, https://doi.org/10.1002/advs.202301348.
APA
Mu, Q., Yao, K., Syeda, M. Z., Zhang, M., Cheng, Q., Zhang, Y., Sun, R., Lu, Y., Zhang, H., Luo, Z., Huang, H., Liu, X., Luo, C., Zhu, X., Wu, S., Cui, L., Huang, C., Chen, X., & Tang, L. (2023). Ligustrazine Nanoparticle Hitchhiking on Neutrophils for Enhanced Therapy of Cerebral Ischemia‐Reperfusion Injury. Advanced Science, 10(19), 1–10. https://doi.org/10.1002/advs.202301348
Chicago
Mu, Qingchun, Kai Yao, Madiha Zahra Syeda, Min Zhang, Qian Cheng, Yufei Zhang, Rui Sun, et al. 2023. “Ligustrazine Nanoparticle Hitchhiking on Neutrophils for Enhanced Therapy of Cerebral Ischemia‐Reperfusion Injury.” Advanced Science 10 (19): 1–10. doi:10.1002/advs.202301348.